NCT04587206

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 With Co-administration of CKD-828, D097 and D337 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 62 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 65 Years
• Healthy volunteers: Accepted

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348

Detailed description

A Phase 1 Clinical Trial to evaluate the tolerability and pharmacokinetics in healthy adult volunteers after administration of CKD-348 and co-administration of CKD-828, D097, D337.

Conditions

• Hypertension and Dyslipidemia

Interventions

Type	Name	Description
DRUG	CKD-348	QD, PO
DRUG	CKD-828, D097, D337	QD, PO

Timeline

• Start date: 2020-10-15
• Primary completion: 2020-12-30
• Completion: 2021-01-15
• First posted: 2020-10-14
• Last updated: 2021-02-04

Locations

1 site across 1 country: South Korea